DemTect effective in screening for mild cognitive impairment and mild dementia.

Does the DemTect reliably detect mild dementia and mild cognitive impairment in older adults?METHODS:Design: Prospective cohort study.Setting: Three centres in the UK; timeframe not stated.People: 121 people aged 45-92 years with possible mild to moderate Alzheimer's disease (NINCDS-ARDRA criteria;...

Descripción completa

Detalles Bibliográficos
Publicado en:Evidence-based Mental Health Vol. 7; no. 3; pp. 70 - 71
Autor principal: Troyer AK
Formato: abstract commentary tables/charts Journal Article
Publicado: BMJ Publishing Group Aug2004
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106782545&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106782545
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        13620347
        99K
      jtl: Evidence-based Mental Health
      issn: 13620347
      maglogo: N
    pubinfo:
      dt: Aug2004
      vid: 7
      iid: 3
      pid: 8280
      pub: BMJ Publishing Group
    artinfo:
      ui:
        106782545
        106782545
        2004162614
        10.1136/ebmh.7.3.70
        NLM15273214
        106782545
      ppf: 70
      ppct: 1
      formats:
      tig:
        atl: DemTect effective in screening for mild cognitive impairment and mild dementia.
      aug:
        au: Troyer AK
        affil: Department of Psychology, Baycrest Centre for Geriatric Care, Toronto, ON, Canada
      sug:
        subj:
          Cognition Disorders Diagnosis
          Neuropsychological Tests Standards
          Predictive Value of Tests
          Prospective Studies
          Scales
      ab: Does the DemTect reliably detect mild dementia and mild cognitive impairment in older adults?METHODS:Design: Prospective cohort study.Setting: Three centres in the UK; timeframe not stated.People: 121 people aged 45-92 years with possible mild to moderate Alzheimer's disease (NINCDS-ARDRA criteria; Clinical Dementia Rating scale (CDR) 1 or 2). 97 people aged 4592 years with mild cognitive impairment (Peterson criteria; CDR 0.5). 145 people aged 45-89 years with no cognitive impairment (CDR 0). Control group was divided into <60 years and >/=60 years. Alzheimer's disease group was divided into Mini-Mental State Examination (MMSE) >/=21 and MMSE <21.Test: The DemTect includes five short, easy to administer tasks that are sensitive for diagnosing dementia (word list; delayed recall of word list; number transcoding; semantic word fluency task; digit span reverse).Diagnostic standard: Full clinical assessment plus CDR to assess dementia and Peterson criteria to assess mild cognitive impairment.Outcomes: Sensitivity and specificity of DemTect and MMSE inClassifying people with mild to moderate Alzheimer's disease and mild cognitive impairment compared with full clinical assessment.MAIN RESULTS:The transformed total DemTcct score is independent of age and education and performed well when compared with MMSE. At a DemTect cut off score of 13, overall classification rate, sensitivity and specificity were high (see table 1; score of 13-18 represents appropriate cognitive power for age). Additional cut off scores were useful for predicting mild cognitive impairment and dementia (mild cognitive impairment; 9-12 points; dementia: 0-8 points; total classification rate: 85.4%).CONCLUSIONS:The DemTect is a useful scale for identifying mild cognitive impairment and early dementia in older adults. It is easy to administer and accepted well by participants.
      pubtype: Academic Journal
      doctype:
        abstract
        commentary
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N